Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.38

View: 9605 Download: 86 Web of Science: 32 Crossref: 31

The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding

Moon Han Choi, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Yu Ri Seo, Min Jin Kim, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(3):280-287. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.280

View: 8403 Download: 61 Crossref: 6

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis

Jong Ho Chung, Hyung Su Ahn, Sang Gyune Kim, Yun Nah Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2013;19(2):156-164. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.156

View: 11037 Download: 125 Crossref: 30

Case Report

Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C

Jae Hee Lim, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee, Tae Kwann Park

Clin Mol Hepatol. 2011;17(1):61-65. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.61

View: 9497 Download: 52 Crossref: 11

1 |

Viewed By 6909	MAFLD: How is it different from NAFLD?
Viewed By 6060	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5255	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5119	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4646	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 295	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search